PGR delivered its May 20 earnings and the market's reaction has been the real story this week: the stock added 2.2% on the week to close at $202.87, a measured response that keeps the fundamental debate firmly unresolved.
The last earnings preview noted that options traders were calm heading into the print, and that proved accurate. The put/call ratio has edged up to 0.78 from 0.76 pre-earnings, still only 0.73 standard deviations above its 20-day average of 0.76. That is nowhere near the defensive extremes the ratio touched late in April at 0.80. The borrow market tells a similarly relaxed story: cost to borrow is running at 0.46% annually — negligible, and broadly flat across the past month. Availability in the lending pool remains effectively unlimited, with the 52-week tightest reading only ever reaching 1.58% utilisation. Nothing in the lending market suggests bears are pressing a short thesis.
Short interest has crept higher this week, but it would be wrong to read too much into it. The float short has risen about 3% over the past five days to 1.25% of free float — up from a low of roughly 1.22% seen mid-May, but still well below the 1.35% level that briefly appeared in late April. Bears have not rebuilt a position of any consequence. The ORTEX short score sits at 30.5, broadly unchanged across the past two weeks, and the short score percentile rank of 68 is a reflection of light positioning relative to history rather than any emerging conviction.
The Street's take is more divided. B of A Securities holds a Buy with a $312 target — well above current levels — and raised its target twice in mid-April following the March monthly data. That $312 level sits far above the consensus mean of $230, and the current price at $203 implies roughly 14% upside to the Street average. But the bull/bear split is real. Morgan Stanley maintains Underweight with a $190 target, sitting below where the stock is trading now. BMO and Wells Fargo are both at market-perform equivalents with targets in the $218–221 range, implying modest single-digit upside. The factor score on analyst recommendation differential ranks at just 8 out of 100 — meaning most of the Street is not bullish. EPS momentum scores are soft: 30 on the 30-day measure and 38 on the 90-day, with forward EPS growth running negative on a year-over-year basis.
Valuation offers a mixed read. The P/E is at 12.5x, down modestly over the past 30 days, while EV/EBITDA has compressed slightly to 7.8x. Neither multiple looks stretched at face value, but the bear case argues that the denominator — earnings — is under pressure as core loss ratios expand and earned rate increases decelerate. The dividend score ranks at the 90th percentile, and the stock does screen as a quality name on ROA and F-score measures. Quality holding up while growth and momentum lag is a recurring theme in the factor profile.
Among the sector peers, ALL led the group with a 4.2% weekly gain, while TRV and CB added around 2.4–2.5%. PGR's 2.2% weekly move tracks the sector closely, suggesting the week's performance was driven more by broad insurance sentiment than anything company-specific out of the May print. The next earnings event is scheduled for July 15 — and that print, not this one, will carry the weight of resolving whether the loss-ratio trajectory is stabilising or continuing to widen.
See the live data behind this article on ORTEX.
Open PGR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
